Adverse events reporting in stage III NSCLC trials investigating surgery and radiotherapy

BACKGROUND: Current treatment options for stage III non-small cell lung cancer (NSCLC) consist of different combinations of chemotherapy, surgery, radiotherapy and immunotherapy. Treatment choices are highly individual decisions, in which adverse events (AEs) are relevant for decision-making. This s...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :ERJ Open Res
Главные авторы: Iseli, Thomas, Berghmans, Thierry, Glatzer, Markus, Rittmeyer, Achim, Massard, Gilbert, Durieux, Valérie, Buchsbaum, Thomas, Putora, Paul Martin
Формат: Artigo
Язык:Inglês
Опубликовано: European Respiratory Society 2020
Предметы:
Original Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7487347/
https://ncbi.nlm.nih.gov/pubmed/32963993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00010-2020
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы